- Home
- VNO vs OPCH Comparison
VNO vs OPCH Comparison
Compare VNO & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$27.06
HOLD
Current Price
$29.90
Company Overview
Basic Information| Metric | VNO | OPCH |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 4.9B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | VNO | OPCH |
|---|---|---|
| Price | $27.06 | $29.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | $36.00 | ★ $37.44 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | ★ 2.61% | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 1.27 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.53 |
| Revenue Next Year | $4.50 | $8.58 |
| P/E Ratio | ★ $7.08 | $23.97 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $25.71 | $24.24 |
| 52 Week High | $43.37 | $36.80 |
Technical Indicators
Market Signals| Indicator | VNO | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 29.16 |
| Support Level | N/A | $29.23 |
| Resistance Level | $32.81 | $31.14 |
| Average True Range (ATR) | 1.09 | 1.25 |
| MACD | -0.02 | -0.54 |
| Stochastic Oscillator | 29.01 | 9.49 |
Price Performance
Historical Comparison VNO
OPCH
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.